Active options: PFE MSTR PLTR NIO MSFT OXY DJT RIOT BA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pfizer (PFE) PT Raised to $31 at CFRA
October 7, 2024 2:55 PM EDTCFRA analyst Sel Hardy raised the price target on Pfizer (NYSE: PFE) to $31.00 (from $30.00) while maintaining a Hold rating.
The analyst comments "We raise our target price to $31 from $30, 10.9x our 2025 EPS, below PFEs historical forward P/E average. We lift our 2024 EPS... More
